These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion. Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma. Jeong J; Choi DW; Choi SH; Heo JS; Jang KT ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800 [TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089 [TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850 [TBL] [Abstract][Full Text] [Related]
6. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection. Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501 [TBL] [Abstract][Full Text] [Related]
7. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns. Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287 [TBL] [Abstract][Full Text] [Related]
8. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer. Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959 [TBL] [Abstract][Full Text] [Related]
9. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy. Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer. Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy. Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer. Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449 [TBL] [Abstract][Full Text] [Related]
15. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952 [TBL] [Abstract][Full Text] [Related]
16. Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma? Jung JP; Zenati MS; Hamad A; Hogg ME; Simmons RL; Zureikat AH; Zeh HJ; Boone BA HPB (Oxford); 2019 Jun; 21(6):679-686. PubMed ID: 30501987 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome? Martin D; Petermann D; Fontanella S; Pu Y; Halkic N; Demartines N; Schäfer M Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1507-1513. PubMed ID: 30222630 [TBL] [Abstract][Full Text] [Related]
18. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer. Zhang XM; Fan H; Kou JT; Zhang XX; Li P; Dai Y; He Q J Gastroenterol Hepatol; 2016 Aug; 31(8):1498-503. PubMed ID: 26825612 [TBL] [Abstract][Full Text] [Related]
19. Pancreatoduodenectomy with superior mesenteric vein resection and non-reconstruction for pancreatic head cancer paying particular attention to hemodynamics. Sugitani J; Ito R; Mise Y; Fujii T; Furuya R; Fujisawa M; Ichida H; Yoshioka R; Saiura A Langenbecks Arch Surg; 2024 Sep; 409(1):273. PubMed ID: 39240392 [TBL] [Abstract][Full Text] [Related]